VNRX - VolitionRx Limited (VNRX) CEO Cameron Reynolds on Q2 2021 Results - Earnings Call Transcript
VolitionRx Limited (VNRX) Q2 2021 Results Conference Call August 12, 2021 08:00 AM ET Company Participants Scott Powell - Executive Vice President of Investor Relations Cameron Reynolds - President and Chief Executive Officer Terig Hughes - Chief Financial Officer Thomas Butera - Chief Executive Officer of Volition Veterinary Diagnostics Development Conference Call Participants Bruce Jackson - Benchmark Company Nathan Weinstein - Aegis Capital Steven Ralston - Zacks Investment Research Michael Okunewitch - Maxim Group Presentation Operator Hello, and welcome to VolitionRx Limited Second Quarter 2021 Financial Results and Business Update Conference Call and Webcast. At this time, all participants are in listen-only mode. [Operator Instructions] A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to turn the call over to Scott Powell, Executive Vice President, Investor Relations. Please go ahead. Scott Powell Thank you, and welcome everyone to
For further details see:
VolitionRx Limited (VNRX) CEO Cameron Reynolds on Q2 2021 Results - Earnings Call Transcript